Ems
Clinical trials sponsored by Ems, explained in plain language.
-
New diabetes combo aims to lower blood sugar in phase 3 trial
Disease control Recruiting nowThis study tests a new drug combination called Piemonte association for people with type 2 diabetes whose blood sugar is not well controlled with current treatments. About 480 adults will receive either the new combination or a placebo to see if it safely lowers blood sugar level…
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New hair lotion aims to thicken thinning hair in men
Disease control Recruiting nowThis study tests a new hair lotion (Finlândia) for men with male pattern baldness. About 190 men aged 18 to 60 who already use minoxidil will use the lotion for 6 months. Researchers will check if it increases hair density and monitor for side effects.
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New diabetes combo drug aims to lower blood sugar in phase 3 trial
Disease control Recruiting nowThis study tests a new combination medicine called Madalena association for people with type 2 diabetes whose blood sugar is not well controlled with two other diabetes drugs. About 270 adults will receive either the new drug or a placebo to see if it safely lowers HbA1c levels. …
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
New combo pill aims to tackle diabetes and cholesterol in one go
Disease control Recruiting nowThis phase 3 trial tests a new combination drug called Berlim 25/20 for people with type 2 diabetes and high cholesterol. The study will see if the drug can lower blood sugar and LDL (bad) cholesterol better than current treatments. About 228 adults aged 18 to 85 who have not rea…
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
New drug could ease menstrual cramps for millions
Symptom relief Recruiting nowThis study tests a new medicine called CDE100 to see if it safely reduces pain from menstrual cramps in women with primary dysmenorrhea. About 238 women aged 16 to 35 with regular periods and a history of moderate to severe cramps will take part. The trial compares CDE100 to a pl…
Phase: PHASE3 • Sponsor: EMS • Aim: Symptom relief
Last updated Jun 08, 2026 13:07 UTC